$115.04 -0.97 (%) Gilead Sciences Inc - NASDAQ

Jul. 2, 2015 | 04:00 PM

Partner Headlines

  1. Japan's Ministry of Health, Labour and Welfare Approves Gilead's Harvoni

    Benzinga | Jul. 3, 2015 | 06:44AM EST
  2. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD | Jul. 1, 2015 | 17:43PM EST
  3. Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide

    Benzinga | Jul. 1, 2015 | 16:30PM EST
  4. What Is Beyond Vision-Loss Blockbuster For Regeneron?

    IBD | Jul. 1, 2015 | 16:12PM EST
  5. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  6. Julian Robertson Discusses Greece Threat, Stocks and Apple

    GuruFocus | Jul. 1, 2015 | 00:10AM EST
  7. Why I Am Buying Gilead Sciences

    GuruFocus | Jun. 30, 2015 | 09:34AM EST
  8. Big Cap Leaders Slide As Much As 4.7%

    IBD | Jun. 29, 2015 | 19:05PM EST
  9. Biotech Short-Sellers Prefer Amgen To Gilead Sciences

    Benzinga | Jun. 27, 2015 | 18:02PM EST
  10. Can Top Stock Gilead Maintain Booming Profit Growth?

    IBD | Jun. 26, 2015 | 18:56PM EST
  11. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD | Jun. 26, 2015 | 17:28PM EST
  12. Can Cambrex Keep Profits Healthy On Gilead Pact?

    IBD | Jun. 26, 2015 | 17:02PM EST
  13. Alan Fournier Sells Stake in Gilead Sciences

    GuruFocus | Jun. 25, 2015 | 19:05PM EST
  14. Gilead Leads 4 Top Stocks In Or Near Top Of Buy Areas

    IBD | Jun. 23, 2015 | 17:18PM EST
  15. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga | Jun. 23, 2015 | 15:38PM EST
  16. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  17. Weekly 52-Week Highs Highlight: GILD, XL, STJ, NKE

    GuruFocus | Jun. 20, 2015 | 18:52PM EST
  18. China Rejects Gilead's Sovaldi Patent Application

    Benzinga | Jun. 20, 2015 | 14:38PM EST
  19. Health Care Stocks Power S&P 500 To Q1 Earnings Beat

    IBD | Jun. 19, 2015 | 17:16PM EST
  20. Biotech ETFs Hit New 2015 Highs

    Benzinga | Jun. 18, 2015 | 14:20PM EST
  21. Stocks Eke Out Quiet Early Gains; FedEx, Adobe Slip On Weak Reports

    IBD | Jun. 17, 2015 | 10:26AM EST
  22. Weekly CFO Sells Highlight: Comcast Corp, Affiliated Managers Group Inc, and Gilead Sciences Inc.

    GuruFocus | Jun. 16, 2015 | 08:57AM EST
  23. Inside IBD Big Cap 20: Some Leaders Rise From Near-Death Levels

    IBD | Jun. 15, 2015 | 18:03PM EST
  24. Winning Streaks Could Send These Medicals Even Higher

    IBD | Jun. 12, 2015 | 17:08PM EST
  25. Big Biotech Stocks See Declining Short Interest

    Benzinga | Jun. 12, 2015 | 07:57AM EST
  26. Gilead, Vasco Data Among Recent Breakouts Holding Up

    IBD | Jun. 11, 2015 | 18:54PM EST
  27. Gilead's President Spoke At Goldman Sachs' Global Healthcare Conference This Week: Here Are The Highlights

    Benzinga | Jun. 11, 2015 | 14:00PM EST
  28. Stocks Edge Higher; Restoration Hardware Slumps Pre-Earnings

    IBD | Jun. 11, 2015 | 13:44PM EST
  29. Benzinga's M&A Chatter for Tuesday June 9, 2015

    Benzinga | Jun. 9, 2015 | 19:18PM EST
  30. Skyworks, Nike Among Big Cap 20 Stocks Pulling Back

    IBD | Jun. 8, 2015 | 18:22PM EST
  31. Are 4 Top-Rated IBD 50 Drug Stocks On Your Radar?

    IBD | Jun. 6, 2015 | 08:02AM EST
  32. Gilead Nears Buy Zone On Healthy Drug Trial Results

    IBD | Jun. 5, 2015 | 18:33PM EST
  33. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD | Jun. 3, 2015 | 08:01AM EST
  34. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD | Jun. 2, 2015 | 18:43PM EST
  35. Top Mutual Funds Add To Medical Holdings

    IBD | Jun. 2, 2015 | 17:52PM EST
  36. Gilead Sciences Pursues Expansion Plans In Canada

    GuruFocus | Jun. 2, 2015 | 13:49PM EST
  37. Gilead Hangs Tough Despite Challenges In Hep C Market

    IBD | May. 29, 2015 | 18:53PM EST
  38. GlobeImmune Hep-B trial fails

    IBD | May. 27, 2015 | 19:02PM EST
  39. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  40. Gilead-GlobeImmune Hepatitis B Drug Fails Trial

    IBD | May. 27, 2015 | 12:57PM EST
  41. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  42. Achillion

    IBD | May. 20, 2015 | 18:39PM EST
  43. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 13:52PM EST
  44. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  45. 5 NASDAQ Healthcare Stocks With The Highest EPS

    Benzinga | May. 20, 2015 | 09:23AM EST
  46. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  47. Achillion, J&J To Jointly Develop Hepatitis C Drugs

    IBD | May. 19, 2015 | 17:07PM EST
  48. Intercept's NASH Trial Design Irks Investors

    IBD | May. 19, 2015 | 11:36AM EST
  49. Buckingham's Top Four New Buys of First Quarter Go Up in Price

    GuruFocus | May. 15, 2015 | 19:25PM EST
  50. Health Care Sector Delivers Healthy Q1 Results

    IBD | May. 15, 2015 | 18:13PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!